Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2021 Apr;124(8):1461-1462.
doi: 10.1038/s41416-021-01280-6. Epub 2021 Feb 16.

Comment on: "Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project"

Mieke R Van Bockstal  1   2 , Louis Libbrecht  3   4   5 , Christine Galant  3   4
Affiliations
Comment

Comment on: "Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project"

Mieke R Van Bockstal et al. Br J Cancer. 2021 Apr.

Erratum in

  • Publisher Correction.
    [No authors listed] [No authors listed] Br J Cancer. 2021 Oct;125(8):1177. doi: 10.1038/s41416-021-01520-9. Br J Cancer. 2021. PMID: 34417578 Free PMC article. No abstract available.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing interests.

Figures

Fig. 1
Fig. 1. Graphs reproduced from Shaaban et al. (Br. J. Cancer 2020; in press), illustrating the cumulative risk of ipsilateral DCIS (left panel) and of ipsilateral invasive carcinoma (right panel) after BCS only.
The in-situ recurrence curve shows a changed slope after 5 years of follow-up (black arrow), illustrated by the full green line (first 5 post-operative years) and the dashed red line (>5 years of follow-up). The invasive recurrence curve shows a steady increase without changed slope, illustrated by the full orange line (right panel).
See this image and copyright information in PMC

Comment in

Comment on

References

    1. Shaaban, A. M., Hilton, B., Clements, K., Provenzano, E., Cheung, S., Wallis, M. G. et al. Pathological features of 11,337 patients with primary ductal carcinoma in situ (DCIS) and subsequent events: results from the UK Sloane Project. Br. J. Cancer, 10.1038/s41416-020-01152-5 (2020). - PMC - PubMed
    1. Portolani N, Coniglio A, Ghidoni S, Giovanelli M, Benetti A, Tiberio GA, et al. Early and late recurrence after liver resection for hepatocellular carcinoma: prognostic and therapeutic implications. Ann. Surg. 2006;243:229–235. doi: 10.1097/01.sla.0000197706.21803.a1. - DOI - PMC - PubMed
    1. Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, et al. Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS. J. Natl Cancer Inst. 2011;103:478–488. doi: 10.1093/jnci/djr027. - DOI - PMC - PubMed
    1. Donker M, Litiere S, Werutsky G, Julien JP, Fentiman IS, Agresti R, et al. Breast-conserving treatment with or without radiotherapy in ductal carcinoma In Situ: 15-year recurrence rates and outcome after a recurrence, from the EORTC 10853 randomized phase III trial. J. Clin. Oncol. 2013;31:4054–4059. doi: 10.1200/JCO.2013.49.5077. - DOI - PubMed
    1. Warnberg F, Garmo H, Emdin S, Hedberg V, Adwall L, Sandelin K, et al. Effect of radiotherapy after breast-conserving surgery for ductal carcinoma in situ: 20 years follow-up in the randomized SweDCIS Trial. J. Clin. Oncol. 2014;32:3613–3618. doi: 10.1200/JCO.2014.56.2595. - DOI - PubMed

MeSH terms

LinkOut - more resources